mhurhangee/patent-ind-claim-en huggingface dataset:
An apparatus for adding, from a gas container with a gas (G), such as a CO 2 gas, put under an overpressure, said gas (G), via a pressure reducing valve unit , to a bottle fully or partly filled with a liquid comprising a two-part valve arrangement , wherein a first part of the arrangement is coupled to the container via a tube or a pipe adapted to extend from a shaped attachment within said first valve part to the pressure reducing valve unit , and a second part of the arrangement is connectable to the bottle , wherein the first part comprises a first check valve which, when being mechanically influenced, permits gas flow from the container via the pressure reducing valve unit , and wherein the second part comprises a second check valve , characterized in that the second check valve , when being pneumatically influenced by the gas flow from the first check valve , permits gas flow from the first check valve and into the bottle , whereby the first part is shaped with an attaching means intended to be able to fixedly interact, as one unit, with a wall section, the two parts of said two-part valve arrangement are easily coordinated with each other and easily separated from each other and wherein the first part is shaped with an upwardly directed pipe section , arranged to be movable upwards and downwards, and the second part is shaped with a downwardly directed channel , adapted in an upwardly directed interacting position, to enclose said pipe section and press this section downwards for a mechanical influence of the check valve to an open position and further wherein said check valves are arranged to arrest the gas within the container and the bottle respectively, simply by separating the parts from each other.
A pulse generating circuit for an electrosurgical generator, the pulse generating circuit comprising: a voltage source connectable to a load via a switching element; an open circuit coaxial transmission line connected between the switching element and the voltage source to be charged by the voltage source when the switching element is in an OFF state and to be discharged when the switching element is in an ON state, wherein the switching element comprises: a plurality of series connected avalanche transistors; and a trigger pulse generator configured to generate a trigger pulse to activate the plurality of series connected avalanche transistors, and wherein the impedance of the coaxial transmission line is configured to match a sum of (i) the impedance the plurality of series connected avalanche transistors, and (ii) the impedance of the load. a voltage source connectable to a load via a switching element; an open circuit coaxial transmission line connected between the switching element and the voltage source to be charged by the voltage source when the switching element is in an OFF state and to be discharged when the switching element is in an ON state, wherein the switching element comprises: a plurality of series connected avalanche transistors; and a trigger pulse generator configured to generate a trigger pulse to activate the plurality of series connected avalanche transistors, and a plurality of series connected avalanche transistors; and a trigger pulse generator configured to generate a trigger pulse to activate the plurality of series connected avalanche transistors, and wherein the impedance of the coaxial transmission line is configured to match a sum of (i) the impedance the plurality of series connected avalanche transistors, and (ii) the impedance of the load.
2,4-Dinitrophenol (DNP), or a pharmaceutically acceptable salt, solvate or hydrate thereof, for use in treating Huntington's Disease, Parkinson's Disease, Epilepsy, or Amyotrophic Lateral Sclerosis, wherein the dose of the 2,4-dinitrophenol (DNP) is in a dose range of 0.01 mg/kg of body weight to 1 mg/kg of body weight, provided that it is not 1 mg/kg of body weight, and wherein the administration frequency is once a day, to attenuate disease progression or provide remission of symptoms. wherein the dose of the 2,4-dinitrophenol (DNP) is in a dose range of 0.01 mg/kg of body weight to 1 mg/kg of body weight, provided that it is not 1 mg/kg of body weight, and wherein the administration frequency is once a day, to attenuate disease progression or provide remission of symptoms.
Part before of a motor vehicle, including: - a bumper cross ; - a front front front top cross ; - a bumper extending in front of the bumper cross and the upper front front cross ; - at least one bumper support plate , attached to the upper front front front cross ; the bumper support plate(s) shall cooperate with the bumper cross in such a way as to support the bumper cross in the event of a head impact on the bumper , characterized by the bumper support plate(s) cooperating with the bumper cross through a bracket attached to the bumper cross , the bracket or each of the brackets comprising a first vertical portion (13.1) mounted on the bumper cross and a second adjacent portion (13.2) to the first portion (13.1) and extending horizontally over the said cross , the bumper bracket(s) containing one or more bumper supports horizontal lower face (9.1) directly opposite the second portion (13.2) of the corresponding bracket and a lower leg (9.2) extending downward before the first portion (13.1) of the corresponding bracket . - a bumper cross ; - a front front front top cross ; - a bumper extending in front of the bumper cross and the upper front front cross ; - at least one bumper support plate , attached to the upper front front front cross ;
A hole injection or transfer layer coating composition for an organic light emitting diode, the coating composition comprising: an organic metal complex of a transition metal; a polymer comprising a unit of the following Chemical Formula 1-2; and an organic solvent: wherein, in Chemical Formula 1-2, X 1 is O or S, X 2 is CR 5 R 6 , O or S, n is an integer of 1 to 10, p is an integer of 1 to 10 and m is an integer of 0 to 10; Y is SO 3 H, SO 3 Li, SO 3 Na, SO 3 K, SO 3 Rb or SO 3 Cs; R 1 to R 6 are each independently hydrogen, fluorine, an alkyl group or a fluoroalkyl group, however, at least one of R 1 and R 2 is fluorine, and s and t mean the number of moles in each parenthesis and are an integer of 1 to 500. an organic metal complex of a transition metal; a polymer comprising a unit of the following Chemical Formula 1-2; and an organic solvent: wherein, in Chemical Formula 1-2, X 1 is O or S, X 2 is CR 5 R 6 , O or S, n is an integer of 1 to 10, p is an integer of 1 to 10 and m is an integer of 0 to 10; Y is SO 3 H, SO 3 Li, SO 3 Na, SO 3 K, SO 3 Rb or SO 3 Cs; R 1 to R 6 are each independently hydrogen, fluorine, an alkyl group or a fluoroalkyl group, however, at least one of R 1 and R 2 is fluorine, and s and t mean the number of moles in each parenthesis and are an integer of 1 to 500.
Method for performing maintenance work on ships, in which at least one parameter for at least one outfitting of the ship is captured by measurement and compared with at least one setpoint value and in which the comparison performed is taken as a basis for triggering performance of a maintenance process, wherein the capture of the parameter by measurement comprises at least one structure-borne sound measurement, wherein the structure-borne sound data are compared with setpoint data and wherein the evaluation of the measurement data involves additional information from an automation and information system of the ship being taken into consideration, characterized in that the automation and information system of the ship is used to access the entire signal inventory of the ship in respect of the ship's operating state and the operating state of the ship's outfittings that are to be tested, wherein a state measurement is performed on a ship's outfitting only if the operating state of the ship and the operating state of the ship's outfitting to be tested are concordant with a prescribed normal measurement state.
A method of selecting a desired template nucleic acid from a population of template nucleic acids, comprising: (a) contacting the population of template nucleic acids with a first oligonucleotide comprising a T m -enhanced oligonucleotide as a blocker to form a mixture; and (b) isolating the desired template nucleic acid from the mixture, wherein the step of contacting the population of template nucleic acids with a first oligonucleotide comprising a T m -enhanced oligonucleotide comprises incubating the mixture at a temperature having a T m value of the T m -enhanced oligonucleotide, wherein the step of isolating the desired template nucleic acid comprises: (i) forming a hybrid complex between the desired nucleic acid and a second oligonucleotide as a bait; and (ii) separating the hybrid complex from the mixture wherein the Tm-enhanced oligonucleotide comprises a plurality of residue groups selected from a group consisting of a locked nucleic acid group, a bicyclic nucleic acid group, a C5-modified pyrimidine, a peptide nucleic acid group, or combinations thereof, the Tm-enhanced oligonucleotide is complementary to non-target nucleic acid and forms a duplex with said non-target nucleic acid sequence selected from adaptor and barcode sequences, and the step of contacting the population of template nucleic acids with a first oligonucleotide comprising a Tm-enhanced oligonucleotide results in the inhibition of complex formation between the desired template nucleic acid and undesired template nucleic acids. (a) contacting the population of template nucleic acids with a first oligonucleotide comprising a T m -enhanced oligonucleotide as a blocker to form a mixture; and (b) isolating the desired template nucleic acid from the mixture, (i) forming a hybrid complex between the desired nucleic acid and a second oligonucleotide as a bait; and (ii) separating the hybrid complex from the mixture
A method of manufacturing III-nitride crystal having a major surface of plane orientation other than designated by choice, the III-nitride crystal manufacturing method including: a step of slicing, from III-nitride bulk crystal, a plurality of III-nitride crystal substrates having a major surface of the designated plane orientation; a step of disposing the substrates adjoining each other sideways in a manner such that the major surfaces of the substrates parallel each other and such that the directions in the substrates are oriented in the same way; and a step of growing III-nitride crystal onto the major surfaces of the substrates, wherein the designated plane orientation is misoriented by an off angle of 5° or less with respect to any crystallographically equivalent plane orientation selected from the group consisting of {1-110x} (wherein x is a whole number of 0 or more), {11-2y} (wherein y is a whole number of 0 or more), and {hk-(h + k)0} (wherein h and k are whole numbers other than 0). a step of slicing, from III-nitride bulk crystal, a plurality of III-nitride crystal substrates having a major surface of the designated plane orientation; a step of disposing the substrates adjoining each other sideways in a manner such that the major surfaces of the substrates parallel each other and such that the directions in the substrates are oriented in the same way; and a step of growing III-nitride crystal onto the major surfaces of the substrates, wherein the designated plane orientation is misoriented by an off angle of 5° or less with respect to any crystallographically equivalent plane orientation selected from the group consisting of {1-110x} (wherein x is a whole number of 0 or more), {11-2y} (wherein y is a whole number of 0 or more), and {hk-(h + k)0} (wherein h and k are whole numbers other than 0).
A patient interface for affixment on onto a patient eye, said patient interface including: - a negative-pressure cavity designed for fluidic coupling to the patient eye, wherein the negative pressure cavity is formed as a suction ring; - a first negative pressure interface with a first negative pressure aperture for fluidically coupling the negative-pressure cavity to a negative-pressure device to charge the negative pressure cavity with a negative pressure; - a second negative pressure interface with a second negative pressure aperture for fluidically coupling the negative-pressure cavity to the negative-pressure device to charge the negative cavity with a negative pressure; wherein the first negative pressure aperture and the second negative pressure aperture are arranged in a circumferential wall of the negative pressure cavity separate from and in close vicinity to each other, wherein an angular distance between the first and second negative pressure aperture does not exceed 30 degrees and/or a distance between the first and second negative pressure aperture does not exceed 5 millimeters. - a negative-pressure cavity designed for fluidic coupling to the patient eye, wherein the negative pressure cavity is formed as a suction ring; - a first negative pressure interface with a first negative pressure aperture for fluidically coupling the negative-pressure cavity to a negative-pressure device to charge the negative pressure cavity with a negative pressure; - a second negative pressure interface with a second negative pressure aperture for fluidically coupling the negative-pressure cavity to the negative-pressure device to charge the negative cavity with a negative pressure;
A wind turbine , comprising: a plurality of wind turbine blades ; a plurality of hydraulic actuators for controlling respective pitch angles of the plurality of wind turbine blades ; a first tank for storing control oil for the plurality of hydraulic actuators ; a first hydraulic pump disposed between the plurality of hydraulic actuators and the first tank , for pumping the control oil; a plurality of valves each of which is provided for corresponding one of the hydraulic actuators , for controlling a supply state of the control oil to the hydraulic actuator ; and a control part for controlling each of the valves, wherein the control part is configured to, in warm-up of a pitch hydraulic system of the plurality of wind turbine blades , for each of the wind turbine blades in turn, control the valve corresponding to the wind turbine blade so as to make the hydraulic actuator corresponding to the wind turbine blade perform an oil transfer operation of changing the pitch angle of the wind turbine blade from a feather side toward a fine side and then returning the pitch angle to the feather side. a plurality of wind turbine blades ; a plurality of hydraulic actuators for controlling respective pitch angles of the plurality of wind turbine blades ; a first tank for storing control oil for the plurality of hydraulic actuators ; a first hydraulic pump disposed between the plurality of hydraulic actuators and the first tank , for pumping the control oil; a plurality of valves each of which is provided for corresponding one of the hydraulic actuators , for controlling a supply state of the control oil to the hydraulic actuator ; and a control part for controlling each of the valves, wherein the control part is configured to, in warm-up of a pitch hydraulic system of the plurality of wind turbine blades , for each of the wind turbine blades in turn, control the valve corresponding to the wind turbine blade so as to make the hydraulic actuator corresponding to the wind turbine blade perform an oil transfer operation of changing the pitch angle of the wind turbine blade from a feather side toward a fine side and then returning the pitch angle to the feather side.
A medical device comprising an elongated body and a resin layer covering at least a proximal portion of the elongated body, wherein the resin layer has a first layer which includes a first fluororesin, an organic pigment, and titanium oxide, and a second layer which is formed on the first layer and includes a second fluororesin.
A catheter grip , consisting of: a generally tubular body: comprising a first end and a second end , having an inner surface and an outer surface, defining a through bore, and configured to slidably engage the shaft of a urinary catheter ; the generally tubular body having a larger diameter at the first end and at the second end than at its middle, characterised in that : the generally tubular body provides a first flare at the first end, a second flare at the second end, and a mid-section at the middle, the smaller relative diameter at the mid-section aiding in positioning a user's fingers toward the middle on the outer surface of the generally tubular body, the inner surface of the generally tubular body configured to contact the urinary catheter along the mid-section when the user applies force thereto. comprising a first end and a second end , having an inner surface and an outer surface, defining a through bore, and configured to slidably engage the shaft of a urinary catheter ;
Transdermal therapeutic system without release-determining membrane for delivering scopolamine, comprising a skin contact layer, an active substance-containing reservoir layer, an active substance-impermeable backing layer, and optionally a protective layer which is detachable from the skin contact layer, wherein the skin contact layer is in direct contact with the active substance-containing reservoir layer, wherein the active substance is present in the form of the free base of scopolamine, the active substance is present in dissolved form in the active substance-containing skin contact layer and is present in part in suspended form in the active substance-containing reservoir layer.
An electrolyte solution for a dye sensitized solar cell, comprising a chain sulfone compound represented by formula as a solvent: wherein R 1 and R 2 each independently represent an alkyl group having from 1 to 12 carbon atoms, which may be partially substituted by a halogen, an alkoxy group or an aromatic ring, an alkoxy group, or a phenyl group, and characterised in that a total number of carbon atoms of R 1 and R 2 is 5 or more.
A tightening screw for osteosynthesis including a thread disposed along a main axis (A), and, at its rear end, a recess having around the main axis (A) regular shapes distributed angularly, adapted to receive complementary shapes of a screwdriver engaging thereon, the rear face of the screw having an inclination relative to a transverse plane of the screw , characterized in that the recess of the screw includes at least one particular shape different from the other regular shapes so as to obtain a unique orientation of the screwdriver when the screwdriver is engaged on the recess of the screw.
Method for determining a wheel circumference (U) of a drive wheel of an electric bicycle , wherein the following step is carried out before a predefined time period (t), • calibrating an acceleration sensor signal, wherein the calibration takes place in the stationary stage of the electric bicycle , and for the calibration an acceleration offset (OS) in the direction of the longitudinal axis of the electric bicycle is determined as a function of a sensed acceleration (a), wherein the following steps are carried out during a predefined time period (t) • sensing a rotational speed (n) of the drive wheel • sensing a profile of an acceleration (a) of the electric bicycle in the direction of the longitudinal axis of the electric bicycle , wherein the subsequent following steps are carried out • determining a distance (s) travelled along by the electric bicycle as a function of the profile of the acceleration (a) which is sensed during the time period (t), • determining the wheel circumference (U) of the drive wheel as a function of the sensed rotational speed (n) and the determined distance (s), and • actuating the drive motor as a function of the determined wheel circumference (U) . • calibrating an acceleration sensor signal, wherein the calibration takes place in the stationary stage of the electric bicycle , and for the calibration an acceleration offset (OS) in the direction of the longitudinal axis of the electric bicycle is determined as a function of a sensed acceleration (a), wherein • sensing a rotational speed (n) of the drive wheel • sensing a profile of an acceleration (a) of the electric bicycle in the direction of the longitudinal axis of the electric bicycle , • determining a distance (s) travelled along by the electric bicycle as a function of the profile of the acceleration (a) which is sensed during the time period (t), • determining the wheel circumference (U) of the drive wheel as a function of the sensed rotational speed (n) and the determined distance (s), and • actuating the drive motor as a function of the determined wheel circumference (U) .
A method for producing a simple emulsion containing two different immiscible fluid phases with a low interfacial tension with a high level of uniformity using a microfluidic device having concentric capillaries, comprising the steps of: introducing an outer phase fluid to an outer capillary of the microfluidic device through a tube ; introducing an inner phase fluid to an inner capillary of the microfluidic device through a flexible tube , the inner fluid being injected within the outer fluid in the microfluidic device at an outlet of the inner capillary; characterised by mechanically vibrating the flexible tubing which brings the inner phase fluid into the microfluidic device so as to create a pressure disturbance therein, whereby encapsulated drops are formed at the output of the microfluidic device , wherein the flexible tubing is vibrated prior to the outlet without vibrating the outlet. introducing an outer phase fluid to an outer capillary of the microfluidic device through a tube ; introducing an inner phase fluid to an inner capillary of the microfluidic device through a flexible tube , the inner fluid being injected within the outer fluid in the microfluidic device at an outlet of the inner capillary; characterised by mechanically vibrating the flexible tubing which brings the inner phase fluid into the microfluidic device so as to create a pressure disturbance therein, whereby encapsulated drops are formed at the output of the microfluidic device , wherein the flexible tubing is vibrated prior to the outlet without vibrating the outlet.